ArticleThe Korean journal of pain2022
Comparison of treatment outcomes in chronic coccygodynia patients treated with ganglion impar blockade
Article in The Korean journal of pain, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07060313 (TARGETING DUAL PATHWAYS IN REFRACTORY COCCYDYNIA), which is not on this map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Targeting dual pathways in refractory coccydynia: a comparative study of ganglion impar block alone versus combined with pericoccygeal injection
Who cites it
12 citing papers in PubMed, 16 citations in OpenAlex.
- [Image-guided plexus and peripheral nerve blocks in modern multimodal pain management].Radiologie (Heidelberg, Germany) · 2026Review
- Management strategies of pediatric coccydynia: a narrative review.Frontiers in pediatrics · 2026Review
- Predictors of Long-Term Response to Ganglion Impar Block With or Without Caudal Epidural Steroid Injection in Chronic Coccydynia: A Retrospective Study.Pain research & management · 2026Observational
- Effective Pain Relief Following Caudal Epidural Block in a Pediatric Patient with Traumatic Sacrococcygeal Dislocation: A Case Report.Children (Basel, Switzerland) · 2025Article
- Chronic Coccygodynia and ganglion impar block: How does contrast material distribution affect treatment outcomes?Pain practice : the official journal of World Institute of Pain · 2025Article
- Management of coccygodynia: talking points from a systematic review of recent clinical trials.Annals of joint · 2025Review
- Coccydynia Improved by Percutaneous Discectomy.Cureus · 2024Article
- A new treatment option for chronic refractory coccygodynia: ultrasound-guided sacral erector spinae plane block.Korean journal of anesthesiology · 2024Article
- Coccygeal Nerve Blockade vs. Impar Ganglion Blockade in Coccydynia: A Randomised Clinical Trial.Cureus · 2024Article
- Article
- Coccydynia: anatomic origin and considerations regarding the effectiveness of injections for pain management.The Korean journal of pain · 2023Review
- Fluoroscopy guided without contrast injection for ganglion impar blockade in traumatic coccydynia: Description a modified approach and 1-year results.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCoccygodynia is one of the chronic, refractory painful musculoskeletal disorders. Interventional procedures are applied to patients unresponsive to initial treatment in coccygodynia. This study aims to compare the treatment outcomes of ganglion impar block (GIB) and caudal epidural steroid injection (CESI) in patients with chronic coccygodynia.
methodsThis study was a prospective randomized comparison study conducted between June 2019 and January 2021. Patients diagnosed with chronic coccygodynia were randomly divided into two groups: the GIB group and the CESI group. The severity of pain, presence of neuropathic pain, and quality of life were evaluated using the Numeric Rating Scale, Leeds Assessment of the Neuropathic Symptoms and Signs Scale, and Short Form-12 Health Survey (SF-12), respectively.
resultsA total of 34 patients in each group were included in the final analyses. While there was a significant decrease in pain intensity in both groups in the 3-month follow-up, this decrease was more significant in the GIB group at the 3rd week. There was a significant improvement in the SF-12 physical score and the number of patients with neuropathic pain in both groups in the 3rd week, but this improvement was not observed in the 3rd month.
conclusionsAlthough GIB may provide more pain relief in short term, both GIB and CESI are useful treatment methods in coccygodynia unresponsive to more conservative treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.